Showing 1 - 10 of 8,921
Persistent link: https://www.econbiz.de/10012889305
The Supreme Court recently held that in reverse-payment settlements of drug patent disputes, anticompetitive effects … can be inferred if the reverse payment exceeds the patent holder's anticipated litigation costs, absent some offsetting … quantifies anticompetitive effects. An otherwise unexplained bump in the patent holder's stock price shows that the settlement …
Persistent link: https://www.econbiz.de/10013004927
Government agencies routinely allow pre-release access to information to accredited news agencies under embargo agreements. Using high frequency data, we find evidence consistent with informed trading during embargoes of the Federal Open Market Committee's scheduled announcements. The E-mini S&P...
Persistent link: https://www.econbiz.de/10013033606
Persistent link: https://www.econbiz.de/10014248279
Persistent link: https://www.econbiz.de/10014574204
Persistent link: https://www.econbiz.de/10012182271
Persistent link: https://www.econbiz.de/10012596763
Persistent link: https://www.econbiz.de/10014557888
Persistent link: https://www.econbiz.de/10012432635
We analyze, theoretically and empirically, how salience affects the market reaction to innovation announcements … investor attention of patent grant and FDA drug approval announcements. We show that, in addition to an announcement effect …, there will be a stock return drift following innovation announcements, with the former magnitude increasing and the latter …
Persistent link: https://www.econbiz.de/10014352443